12 rezultati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to a method for topically treating inflammation in humans or animals. More particularly, the invention relates to a method of treating inflammation in humans and animals with acetylsalicylic acid esters.
2.
BACKGROUND OF THE INVENTION
The present invention relates to compositions and processes for relieving inflammation. More specifically, vehicles comprising monoolein and a diol having 3 or 4 carbon atoms are surprisingly effective carriers for the topical administration of acetylsalicylic
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase patent application of PCT/NO2014/050116, filed on Jun. 26, 2014, which claims priority to Norwegian Patent Application No. 20130889, filed on Jun. 27, 2013, the disclosures of which are hereby incorporated by reference
BACKGROUND OF THE INVENTION
This invention relates to a pharmaceutical composition for the treatment of cutaneous disorders or disruptions characterized by skin inflammation and/or hyperproliferative activity in the epidermis. More specifically, the invention comprises treatment of such disorders by
FIELD OF INVENTION
The present invention relates in general to acetylsalicylic acid salts, and in particular to a new and useful water soluble acetylsalicylic acid salts and the method of making the same. Acetylsalicylic acid is a most widely used drug, known chiefly for its analgesic properties.
The invention relates to the potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs.
Despite the fact that more refined drugs are available and that asthma care is better overall, nevertheless the mortality and morbidity of
The invention relates to the potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs.
Despite the fact that more refined drugs are available and that asthma care is better overall, nevertheless the mortality and morbidity of
It is known that 1-(5-oxohexyl)-3,7-dimethylxanthine (pentoxifylline) is used as a pharmaceutical agent for the improvement of the flow properties of blood. The supposed cause of this is (Deutsche mediz, Wochenschrift 107 (1982), 1674) that the viscous stress of the blood decreases because the
BACKGROUND OF THE INVENTION
The present invention relates to compositions and processes for relieving inflammation. More specifically, vehicles comprising monoolein and a diol having 3 or 4 carbon atoms are surprisingly effective carriers for the topical administration of acetylsalicylic
FIELD OF INVENTION
This invention involves compositions of anti-inflammatory agents for the treatment and prevention of disorders associated with endothelial dysfunction.
BACKGROUND OF THE INVENTION
Endothelial cells are mesodermally derived, simple squamous epithelial cells that line the heart,
This invention relates to aspirin-isopropylantipyrine (N-3'a-propylphenazonyl-2-acetoxybenzamide), a compound that has yet to be found in known literature, a process for producing same, and its utilization as an analgetic, antipyretic and anti-inflammatory agent.
More specifically, this invention
TECHNICAL FIELD
The treatment of major depressive disorder, bipolar depression, the negative symptoms of schizophrenia, and depression secondary to general medical conditions remains a major challenge for psychiatry. The present disclosure provides improvements in compositions and methods for